AstraZeneca, Pharmaceutical Development, Silk Road Business Park, Charter Way, Macclesfield, Cheshire SK10 2NA, UK.
J Org Chem. 2011 Mar 18;76(6):1653-61. doi: 10.1021/jo102262k. Epub 2011 Feb 4.
The reaction of quinazolones with POCl(3) to form the corresponding chloroquinazolines occurs in two distinct stages, which can be separated through appropriate temperature control. An initial phosphorylation reaction occurs readily under basic conditions (R(3)N, aq pK(a) > 9) at t < 25 °C to give a variety of phosphorylated intermediates. Pseudodimer formation, arising from reaction between phosphorylated intermediates and unreacted quinazolone, is completely suppressed at these temperatures, provided the system remains basic throughout the POCl(3)addition. Clean turnover of phosphorylated quinazolones to the corresponding chloroquinazoline is then achieved by heating to 70-90 °C. (N)- and (O)-phosphorylated intermediates, involving multiple substitution at phosphorus, have been identified and their reactions monitored using a combination of (1)H, (31)P, and (19)F NMR. Kinetic analysis of the reaction profiles suggest that the various intermediates react with both Cl(-) and Cl(2)P(O)O(-), but product formation arises exclusively from reaction of (O)-phosphorylated intermediates with Cl(-). (O)- and (N)-phosphorylated intermediates equilibrate rapidly on the time scale of the reaction. A minimum of 1 molar equiv of POCl(3) is required for efficient conversion of the intermediates to product.
喹唑啉与 POCl(3)的反应分为两个不同的阶段,通过适当的温度控制可以将它们分离。在碱性条件下(R(3)N,aq pK(a) > 9),温度低于 25°C 时,很容易发生初始的磷酸化反应,生成各种磷酸化中间体。在这些温度下,只要体系在整个 POCl(3)添加过程中保持碱性,磷酸化中间体和未反应的喹唑啉之间的假二聚体形成就会完全被抑制。通过加热至 70-90°C,可以实现磷酸化喹唑啉向相应的氯喹唑啉的清洁转化。已经鉴定出涉及磷上多取代的 (N)-和 (O)-磷酸化中间体,并使用 (1)H、(31)P 和 (19)F NMR 对其反应进行了监测。反应曲线的动力学分析表明,各种中间体与 Cl(-)和 Cl(2)P(O)O(-)都反应,但产物的形成仅来自于 (O)-磷酸化中间体与 Cl(-)的反应。(O)-和 (N)-磷酸化中间体在反应时间尺度上迅速达到平衡。至少需要 1 摩尔当量的 POCl(3)才能有效地将中间体转化为产物。